Linopristin/flopristin

< Linopristin
Linopristin/flopristin
Combination of
LinopristinStreptogramin B antibiotic
FlopristinStreptogramin A antibiotic
Clinical data
Other namesNXL103; XRP 2868
Identifiers
CAS Number

Linopristin/flopristin (development codes NXL103 and XRP 2868) is an experimental drug candidate under development by Novexel. It is an oral streptogramin antibiotic that has potent in vitro activity against certain Gram-positive bacteria including methicillin resistant Staphylococcus aureus (MRSA), as well as the important respiratory pathogens including penicillin-, macrolide- and quinolone-resistant strains. It is a combination of linopristin and flopristin.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.